ArticleRSC medicinal chemistry2021

Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood-brain barrier permeability.

Chiara Borsari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.